To further characterize changes in CDH2 expression during chemotherapy in ovarian cancer, we cross-validated our findings using Single-cell RNA sequencing (scRNA-seq) data from clinical ovarian cancer samples (GSE211956). This evidence concerns the gene CDH2 and ovarian cancer.